Prospective cohort finds botulinum neurotoxin injection improved sleep quality in cervical dystonia, with no significant mood ...
NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced positive topline results ...
March 6, 2012 (Vienna, Austria) — The use of ultrasound to guide transforaminal epidural steroid injections (TF-ESIs) for the treatment of cervical radiculopathy is an effective radiation-free ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the company will present an ...
Dr. Dawley and colleagues sought to affirm the possibility that intra-arterial injection of commonly used corticosteroids could lead to central nervous system injury during a transforaminal epidural ...
ROCKVILLE, Md., Oct. 24, 2011 /PRNewswire via COMTEX/ -- Neuralstem, Inc. updated the progress of its ongoing Phase I safety trial of the company's spinal cord stem cells in the treatment of ...
- DaxibotulinumtoxinA for Injection was effective and generally well-tolerated in reducing the signs and symptoms for cervical dystonia, delivering up to a median duration of 24 weeks - - Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results